Arizona Biosciences News
Share on Twitter
Share on Facebook
Email to a friend
Print ArticleASU cancer discovery proving successful
Summary:
Clinical trials are holding promise for a new cancer drug whose roots can be traced to Arizona State University.
Full Story:
Clinical trials are holding promise for a new cancer drug whose roots can be traced to Arizona State University.
According to The Arizona Republic, a compound synthesized from an African willow tree is proving successful in damaging blood vessels that feed solid cancer tumors. Such vascular-targeting agents are being hailed as the next generation of anti-cancer drugs.
Oxigene, a Massachusetts biotech firm, is working to commercialize a drug based on the research of ASU's Cancer Research Institute. Institute director G. Robert Pettit identified and isolated the compound in 1987.
For more information:
Quick Links
- NEW: About the Arizona Center for Civic Leadership
- Arizona Biosciences News
- Arizona BioMap
- Roadmap Progress Updates
- Reports & Multimedia
- Timeline: Arizona's Bio Growth
- Arizona Bio Orgs on Twitter
- Arizona BioBasics
- The Biozona Brand
- Newsletter Signup
Download a new brochure from the Flinn Foundation outlining the 2011 progress on Arizona's Bioscienced Roadmap: a record high in bioscience jobs, plus gains in firms and venture-capital funding. Numerous achievements during the year advanced the core strategies of the Roadmap.
Also, read the full Performance Assessment describing in detail Arizona's 2011 progress on key Roadmap metrics.
